Graduate Biostatistician - UK

Key Skills

Analytical and Problem solving, Biostatistics, C++, Python Programming, R Programming, SAS, SQL, Statistics

Job Description

Labcorp Drug Development is excited to launch the 2023 Graduate Scheme for Biostatistics in the United Kingdom. Labcorp is a global life sciences company that brings diagnostic testing and drug development together and this graduate scheme is an opportunity to join the Drug Development division of Labcorp to start a career as a Biostatistician in clinical research.

Starting in October 2023, the graduate scheme will combine comprehensive SAS programming tuition from our partner Amadeus Software, a market leader in this field, with tailored internal training on the drug development process with a key focus on the analysis and reporting of clinical trials.

Location

Labcorp Drug Development utilises a hybrid approach to working, combining office and homebased working to best fit the needs of the individual and the company. There is an expectation that the graduates will be primarily office based, allowing the intake to bond and thrive with expert support always on hand.

With this in mind, the scheme will be available in our brand new office facilities in Leeds - West Yorkshire.

Education

A minimum qualification of an MSc. in Statistics or related field is required. Please note at the time of starting your employment you must have permission to work in the UK.

What else can you expect from us?

• Rewarding and meaningful work in an established, diverse, highly profitable and respected global company
• An intensive and comprehensive training curriculum, developed and delivered by Labcorp’s biostatistics experts, that is designed to jumpstart your programming career in clinical research
• A permanent employment contract with Labcorp Drug Development
• Highly competitive compensation packages
• Excellent training and career development opportunities, a transparent, continuous feedback culture, and strictly merit-based career progression models for both aspiring people managers and subject matter experts
• Strong support from your Labcorp Line Manager and your team, as well as from more than 20,000 Labcorp Drug Development colleagues worldwide

Your role:

• Conduct overall statistical review of TFLs for medium complexity studies prior to client delivery.
• Preparation of Statistical Analysis Plans (including mock TFL shells) for simple and medium complexity studies under the supervision of senior statistical staff.
• Perform statistical analysis for medium complexity studies.
• Review Clinical Report Form and other study specific specifications and plans.
• Provide statistical input and review of the Clinical Study Report for simple studies.
• Generation and review of randomization schedules from provided specifications under the supervision of senior statistical staff

Your profile:

• Degree in a relevant field such as statistics, medical statistics, biostatistics, computer sciences, data science, etc.
• First programming experience in SAS, R, Python, C++, SQL, etc. is nice to have, but no must
• Strong organizational and communication skills
• A collaborative work style, good problem solving skills, and the ability to learn new systems and flourish in an evolving technical environment

As a leading contract research organization (CRO), Labcorp Drug Development provides comprehensive drug development solutions for a range of industries. Our services cover the preclinical, clinical and post-market phases of drug development, the product life cycles for medical device and diagnostics and development services paired with regulatory support for the chemical testing and crop protection industries.

Labcorp Drug Development is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services. Our unique perspectives are based on decades of scientific, medical and regulatory expertise.

Did you know?

In July 2022, Labcorp announced its intention to spin off its clinical development business as a separate public company, subject to the satisfaction of certain customary conditions. Fortrea will become the new brand identity for our Clinical Development business in connection with the spin-off, which is expected in mid-2023.

We believe that the exceptional is possible when you have the right partner, so we are looking for the right people to help build a transformative force in Clinical Development.www.fortrea.com

Labcorp is proud to be an Equal Opportunity Employer:

As an EOE/AA employer, Labcorp strives for diversity and inclusion in the workforce and does not tolerate harassment or discrimination of any kind. We make employment decisions based on the needs of our business and the qualifications of the individual and do not discriminate based upon race, religion, color, national origin, gender (including pregnancy or other medical conditions/needs), family or parental status, marital, civil union or domestic partnership status, sexual orientation, gender identity, gender expression, personal appearance, age, veteran status, disability, genetic information, or any other legally protected characteristic. We encourage all to apply.

For more information about how we collect and store your personal data, please see our Privacy Statement.